
Colimista 3MIU Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Colistimethate Sodium (3Million IU)
Overview Colimista 3MIU Injection
Colomycin 3MIU Injection, an antibacterial medication, combats severe systemic bacterial infections. Primarily administered to hospitalized patients in critical condition, this injection requires professional healthcare oversight; self-administration is strictly prohibited. Dosage and treatment length are determined by your physician based on infection severity and type. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Potential adverse effects, such as nausea, difficulty speaking, lightheadedness, vertigo, pyrexia, skin eruptions, and tingling sensations, are typically transient and resolve with continued therapy. Persistent or bothersome side effects warrant immediate medical consultation. Prior to commencing treatment, disclose any antibiotic allergies, liver or kidney impairments to your physician. Pregnant or lactating individuals should seek medical advice before use. Regular blood tests may be ordered to monitor renal function and drug levels.
Uses of Colimista 3MIU Injection
Life-threatening bacterial infestations
Major Benefits of Colimista 3MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Colimista 3MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Colimista 3MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Colimista 3MIU Injection works:
Colimista 3MIU Injection is a bactericidal antibiotic that works by disrupting bacterial cell membranes.
SAFETY ADVICE
AlcoholSAFE
Colimista 3MIU Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Employing Colimista 3MIU Injection during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Colimista 3MIU Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Colimista 3MIU Injection might reduce awareness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, the administration of Colimista 3MIU Injection requires careful consideration. A modified dosage of Colimista 3MIU Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Colimista 3MIU Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Colimista 3MIU Injection :
NA
Facts to Know About Colimista 3MIU Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
